IMNN
Imunon Inc
NASDAQ: IMNN · HEALTHCARE · BIOTECHNOLOGY
$2.83
+5.60% today
Updated 2026-04-30
Market cap
$10.98M
P/E ratio
—
P/S ratio
17.94x
EPS (TTM)
$-6.83
Dividend yield
—
52W range
$3 – $36
Volume
0.1M
Imunon Inc (IMNN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-256.40%
ROA
-83.20%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $11.25M | $-7.58M | 40.72% | -75.43% | -67.41% |
| 2007 | — | $35.35M | — | — | — |
| 2008 | $2.50M | $-11.79M | 100.00% | -461.98% | -471.45% |
| 2009 | — | $-15.19M | — | — | — |
| 2010 | — | $-18.82M | — | — | — |
| 2011 | $2.00M | $-23.22M | 100.00% | -1,150.94% | -1,161.13% |
| 2012 | — | $-26.57M | — | — | — |
| 2013 | $500000.00 | $-8.25M | 100.00% | -3,082.30% | -1,650.27% |
| 2014 | $500000.00 | $-25.49M | 100.00% | -4,943.04% | -5,098.85% |
| 2015 | $500000.00 | $-22.46M | 100.00% | -4,169.36% | -4,492.22% |
| 2016 | $500000.00 | $-22.05M | 100.00% | -4,129.96% | -4,410.75% |
| 2017 | $500000.00 | $-20.40M | 100.00% | -3,693.69% | -4,080.44% |
| 2018 | $500000.00 | $-11.88M | 100.00% | -4,213.01% | -2,376.67% |
| 2019 | $500000.00 | $-16.85M | 100.00% | -4,113.09% | -3,370.31% |
| 2020 | $500000.00 | $-21.48M | 100.00% | -3,697.28% | -4,296.71% |
| 2021 | $500000.00 | $-20.77M | 100.00% | -4,201.44% | -4,153.85% |
| 2022 | $500000.00 | $-35.90M | 100.00% | -4,984.31% | -7,179.65% |
| 2023 | $125000.00 | $-19.51M | -576.00% | -16,824.34% | -15,611.98% |
| 2024 | $0.00 | $-18.62M | — | — | — |
| 2025 | $0.00 | $-14.49M | — | — | — |